Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group

The purpose of this study was to evaluate clinical characteristics, treatment, and survival of children, who were diagnosed with hepatoblastoma (HB) in their first 6 months of age, enrolled in the SIOPEL 2 and 3 protocols.

[1]  M. Stevens,et al.  Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience. , 2016, European journal of cancer.

[2]  T. Hishiki,et al.  The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. , 2016, European journal of cancer.

[3]  E. Hiyama,et al.  Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy , 2014, Current opinion in pediatrics.

[4]  J. Karpelowsky,et al.  Outcomes of pulmonary metastases in hepatoblastoma--is the prognosis always poor? , 2013, Journal of pediatric surgery.

[5]  M. Rodriguez-Davalos,et al.  Current concepts in pediatric liver tumors , 2012, Pediatric transplantation.

[6]  B. Morland,et al.  Prognostic stratification for children with hepatoblastoma: the SIOPEL experience. , 2012, European journal of cancer.

[7]  B. Haeberle,et al.  Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studies. , 2012, Frontiers in bioscience.

[8]  H. Katzenstein,et al.  Treatment of hepatoblastoma: the North American cooperative group experience. , 2012, Frontiers in bioscience.

[9]  F. Berthold,et al.  Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project. , 2011, European journal of cancer.

[10]  G. Perilongo,et al.  Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Kondo,et al.  Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT , 2010, Pediatric Surgery International.

[12]  B. Morland,et al.  Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. , 2009, The New England journal of medicine.

[13]  G. Perilongo,et al.  Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. , 2008, European journal of cancer.

[14]  H. Katzenstein,et al.  Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma. , 2007, Journal of pediatric surgery.

[15]  K. McHugh,et al.  2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group , 2006, Pediatric Radiology.

[16]  G. Perilongo,et al.  Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2. , 2004, European journal of cancer.

[17]  D. Heilbron,et al.  Expressing glomerular filtration rate in children , 2004, Pediatric Nephrology.

[18]  D. Heilbron,et al.  Expressing glomerular filtration rate in children , 2004, Pediatric Nephrology.

[19]  D. V. von Schweinitz,et al.  [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99]. , 2003, Klinische Padiatrie.

[20]  G. Perilongo,et al.  Hepatoblastoma presenting with lung metastases , 2000, Cancer.

[21]  G. Perilongo,et al.  Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. , 2000, European journal of cancer.

[22]  G. Perilongo,et al.  Hepatoblastoma presenting with lung metastases: Treatment results of the first cooperative, prospective study of the International Society of paediatric Oncology on childhood liver tumors , 2000 .

[23]  K. Leibundgut,et al.  Congenital hepatoblastoma: a distinct entity? , 1999, Medical and pediatric oncology.

[24]  C. R. Pinkerton,et al.  Cisplatin ototoxicity in children: a practical grading system. , 1991, Medical and pediatric oncology.